These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Novel pharmacological strategies for aortic dilation in Marfan syndrome: from mouse models to human patients].
    Author: Perrino C, Schiattarella GG, Bottino R, Magliulo F, Oliveti M, Esposito G, Trimarco B.
    Journal: G Ital Cardiol (Rome); 2014; 15(7-8):408-17. PubMed ID: 25174594.
    Abstract:
    Marfan syndrome (MS) is a congenital disorder of the connective tissue characterized by aortic dilation with frequent progression to aortic aneurysms requiring surgical intervention. Although mutations in the fibrillin-1 (FBN1) gene have been recognized as the genetic cause of MS a long time ago, only recently deeper knowledge of the molecular mechanisms underlying fibrillin-1 biology and the crucial role of transforming growth factor-β and angiotensin II receptor type 1 antagonists have been elucidated. This review focuses on the most commonly used animal models to investigate the molecular mechanisms underlying MS, and on novel pharmacological strategies to reduce aortic dilation in MS.
    [Abstract] [Full Text] [Related] [New Search]